The Expression Level and Prognostic Value of Y-Box Binding Protein-1 in Rectal Cancer

被引:1
|
作者
Zhang, Yu [1 ,2 ]
Zhao, Ping-Wu [3 ]
Feng, Gang [1 ]
Xie, Gang [4 ]
Wang, An-Qun [4 ]
Yang, Yong-Hong [4 ]
Wang, Dong [2 ,3 ]
Du, Xiao-Bo [1 ]
机构
[1] MianYang Cent Hosp, Dept Oncol, Mianyang, Peoples R China
[2] LuZhou Med Coll, Dept Surg, Luzhou, Peoples R China
[3] MianYang Cent Hosp, Dept Surg, Mianyang, Peoples R China
[4] MianYang Cent Hosp, Dept Pathol, Mianyang, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 03期
关键词
TRANSCRIPTION FACTOR YB-1; PREDICTIVE MARKER; POOR SURVIVAL; RISK-FACTORS; RESISTANCE; CELLS; PROLIFERATION; SENSITIVITY; CISPLATIN; DISEASE;
D O I
10.1371/journal.pone.0119385
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aims of this study were to simultaneously evaluate the expression of Y-box binding protein-1 (YB-1) in non-neoplastic rectal tissue and rectal cancer tissue, and to collect clinical follow-up data for individual patients. Additionally, we aimed to investigate the developmental functions and prognostic value of YB-1 in rectal cancer. We performed immunohistochemical studies to examine YB-1 expression in tissue samples from 80 patients with rectal cancer, 30 patients with rectal tubular adenoma, and 30 patients with rectitis. The mean YB-1 histological scores for rectal cancer, rectal tubular adenoma, and rectitis tissue specimens were 205.5, 164.3, and 137.7, respectively. Shorter disease-free and overall survival times were found in patients with rectal cancer who had higher YB-1 expression than in those with lower expression (38.2 months vs. 52.4 months, P = 0.013; and 44.4 months vs. 57.3 months, P = 0.008, respectively). Our results indicate that YB-1 expression is higher in rectal cancer tissue than in rectal tubular adenoma and rectitis tissue and that it may be an independent prognostic factor for rectal cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Alteration of Y-box Binding Protein-1 Expression Modifies the Response to Endocrine Therapy in Estrogen Receptor Positive Breast Cancer.
    Ito, T.
    Kamijo, S.
    Izumi, H.
    Kohno, K.
    Ito, K-I
    CANCER RESEARCH, 2011, 71
  • [22] Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer
    Tokiko Ito
    Shinobu Kamijo
    Hiroto Izumi
    Kimitoshi Kohno
    Jun Amano
    Ken-ichi Ito
    Breast Cancer Research and Treatment, 2012, 133 : 145 - 159
  • [23] The antiestrogens 4-hydroxytamoxifen and fulvestrant are inhibitors of oncogenic factor Y-box binding protein-1 expression in breast cancer cells
    Stope, M. B.
    Popp, S. L.
    Joffroy, C.
    Mustea, A.
    Buck, M. B.
    Knabbe, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (05) : 764 - 768
  • [24] Y-box binding protein 1-A prognostic marker and target in tumour therapy
    Kosnopfel, Corinna
    Sinnberg, Tobias
    Schittek, Birgit
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2014, 93 (1-2) : 61 - 70
  • [25] Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors
    Lettau, Konstanze
    Khozooei, Shayan
    Kosnopfel, Corinna
    Zips, Daniel
    Schittek, Birgit
    Toulany, Mahmoud
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 1072 - 1087
  • [26] Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma
    Fujiwara-Okada, Y.
    Matsumoto, Y.
    Fukushi, J.
    Setsu, N.
    Matsuura, S.
    Kamura, S.
    Fujiwara, T.
    Iida, K.
    Hatano, M.
    Nabeshima, A.
    Yamada, H.
    Ono, M.
    Oda, Y.
    Iwamoto, Y.
    BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 836 - 847
  • [27] Y-box binding protein-1 implicated in translational control of fetal myocardial gene expression after cardiac transplant
    David, Jason J.
    Subramanian, Sukanya V.
    Zhang, Aiwen
    Willis, William L.
    Kelm, Robert J., Jr.
    Leier, Carl V.
    Strauch, Arthur R.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 237 (05) : 593 - 607
  • [28] Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma
    Y Fujiwara-Okada
    Y Matsumoto
    J Fukushi
    N Setsu
    S Matsuura
    S Kamura
    T Fujiwara
    K Iida
    M Hatano
    A Nabeshima
    H Yamada
    M Ono
    Y Oda
    Y Iwamoto
    British Journal of Cancer, 2013, 108 : 836 - 847
  • [29] HIGH-RISK EPENDYMOMAS ARE DISTINGUISHABLE BY ELEVATED EXPRESSION OF THE EPIDERMAL GROWTH FACTOR AND THE Y-BOX BINDING PROTEIN-1
    Hukin, J.
    Law, J. H.
    Yip, S.
    Maguire, J.
    Yamashita, T.
    Fryer, C.
    Singhal, A.
    Ailon, T.
    Hendson, G.
    Hawkins, C.
    Dunn, S. E.
    NEURO-ONCOLOGY, 2010, 12 (06) : II26 - II26
  • [30] Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer
    Panupinthu, N.
    Yu, S.
    Zhang, D.
    Zhang, F.
    Gagea, M.
    Lu, Y.
    Grandis, J. R.
    Dunn, S. E.
    Lee, H. Y.
    Mills, G. B.
    ONCOGENE, 2014, 33 (22) : 2846 - 2856